Form 4 for TDOC Teladoc Health, Inc.
Accepted 2023-07-28 00:00:00 ET · period of report 2023-07-27 · accession 0001477449-23-000016 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-28 | 2023-07-27 | TDOC | GOREVIC JASON N | CEO, Dir | S - Sale | $30.03 | -10.0K | 596.2K | -2% | -$300.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-27 | S | D | 10,000 | $30.03 | 596,246 | D | — | — | (F2) Represents the weighted average price of transactions ranging from $30.00 to $30.07, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. |